ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+4.57%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$5.71B
AUM Growth
+$5.71B
(-11%)
Cap. Flow
-$801M
Cap. Flow
% of AUM
-14.03%
Top 10 Holdings %
Top 10 Hldgs %
73.58%
Holding
34
New
1
Increased
10
Reduced
17
Closed
4
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$187M |
| 2 |
MoonLake Immunotherapeutics
MLTX
|
$65.1M |
| 3 |
uniQure
QURE
|
$20.2M |
| 4 |
Vera Therapeutics
VERA
|
$14.1M |
| 5 |
Alkermes
ALKS
|
$12.9M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$445M |
| 2 |
Sarepta Therapeutics
SRPT
|
$171M |
| 3 |
United Therapeutics
UTHR
|
$87.6M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$82.5M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
$44.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
MannKind Corp
MNKD
$1.41B
| $21.9M | 0.38% | 5,850,000 -2,900,000 | -33% | -$10.8M |
|
27
Monte Rosa Therapeutics
GLUE
$296M
| $16.8M | 0.29% | 3,725,000 -920,548 | -20% | -$4.15M |
|
|
SEPN
28
Septerna, Inc. Common Stock
SEPN
$539M
| $13.1M | 0.23% | 1,237,500 -100,000 | -7% | -$1.06M |
|
29
Ultragenyx Pharmaceutical
RARE
$2.89B
| $12M | 0.21% | 330,000 -500,000 | -60% | -$18.2M |
|
|
WHWK
30
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $5.33M | 0.09% | 2,849,402 | – | – |
|
|
AUTL
31
Autolus Therapeutics
AUTL
$399M
| – | – | -9,910,642 | Closed | -$15.4M |
|
32
Vaxcyte
PCVX
$4B
| – | – | -1,000,000 | Closed | -$37.8M |
|
|
33
Sarepta Therapeutics
SRPT
$1.78B
| – | – | -2,674,835 | Closed | -$171M |
|
|
ITCI
34
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – | -625,000 | Closed | -$82.5M |
|